JELVOXA DMSO
- Product NDC
- 88041-002
- Requested package NDC
- 88041-002-01
- 11-digit product format
- 880410002
- Labeler code
- 88041
- Product ID
- 88041-002_5d43aff1-a87c-43a3-e063-6294a90af642
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- MENTHOL Camphor Capsaicin
- Dosage form
- CREAM
- Route
- TRANSDERMAL
- Labeler
- Vange Life Technology Co., Limited
- Application
- M017
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2026-10-08
- Substance
- CAMPHOR (SYNTHETIC); MENTHOL; CAPSAICIN
- Active strength
- 4; 3; .025 g/100g; g/100g; g/100g
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- JELVOXA DMSO
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| CAMPHOR (SYNTHETIC) | 4 g/100g |
| MENTHOL | 3 g/100g |
| CAPSAICIN | .025 g/100g |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 88041-002-01 | 88041000201 | 120 g in 1 BOTTLE (88041-002-01) | 120 g | 2026-10-08 | No | No | Current |